Cullinan Oncology
CGEM
CGEM
75 hedge funds and large institutions have $559M invested in Cullinan Oncology in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 29 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
5.51% more ownership
Funds ownership: 77.77% → 83.28% (+5.5%)
0% more call options, than puts
Call options by funds: $1K | Put options by funds: $1K
27% less capital invested
Capital invested by funds: $762M → $559M (-$203M)
Holders
75
Holding in Top 10
6
Calls
$1K
Puts
$1K
Top Buyers
| 1 | +$71.5M | |
| 2 | +$12.5M | |
| 3 | +$3.99M | |
| 4 |
CA
CHI Advisors
New York
|
+$3.58M |
| 5 |
BlackRock
New York
|
+$3.23M |
Top Sellers
| 1 | -$24.5M | |
| 2 | -$24.1M | |
| 3 | -$15.9M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$6.63M |
| 5 |
DM
Deerfield Management
New York
|
-$5.74M |